ARCHIVES

NCI Budget 6% Below 1980 Level; Prevention, Groups, Lost Most

This article is from The Cancer Letter archive.

Vol. 17 No. 06 | February 8, 1991

Download PDF Visit The Full Archive

Related Articles

NCAB To Hear Details Of New Grant Program, Hanna’s Frederick Plans

November 15, 1974

Cancer, AIDS Drug Screening Contracts Ok’d For Recompetition

February 28, 1992

ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial.

September 8, 2006

RFA On Natural Inhibitors Role In Prevention Released

April 2, 1982

FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment.

December 17, 2013

Also ASCO to release abstracts to members prior to annual meeting.

January 30, 2004